MIGUEL JOSÉ
MARTÍN JIMÉNEZ
Catedrático de universidad
![Foto de MIGUEL JOSÉ](/img/nophoto.png)
![Foto de University of Sydney](/img/noimage_org.png)
University of Sydney
Sídney, AustraliaPublications in collaboration with researchers from University of Sydney (8)
2022
-
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies
Journal for immunotherapy of cancer, Vol. 10, Núm. 2
2021
-
Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial
Clinical Breast Cancer, Vol. 21, Núm. 1, pp. 80-91.e7
-
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
npj Breast Cancer, Vol. 7, Núm. 1
2018
-
Efficacy of chemotherapy for ER-negative and ER-positive isolated locoregional recurrence of breast cancer: Final analysis of the CALOR trial
Journal of Clinical Oncology, Vol. 36, Núm. 11, pp. 1073-1079
2017
-
Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial
Annals of Surgical Oncology, Vol. 24, Núm. 2, pp. 398-406
2015
-
Aromatase inhibitors versus tamoxifen in early breast cancer: Patient-level meta-analysis of the randomised trials
The Lancet, Vol. 386, Núm. 10001, pp. 1341-1352
2014
-
Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): A randomised trial
The Lancet Oncology, Vol. 15, Núm. 2, pp. 156-163
2005
-
Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005
Annals of Oncology, Vol. 16, Núm. 10, pp. 1569-1583